Stenlose, Denmark

Kasper Lamberth

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Novo Nordisk A/s, Sanquin Blood Supply Foundation. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kasper Lamberth. Retrieved from https://idiyas.com/inventor/kasper-lamberth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Kasper Lamberth

Introduction:

In the realm of inventions and patents, one name stands out - Kasper Lamberth. Hailing from Stenloese, DK, this prolific inventor has made significant contributions to the field with his groundbreaking work.

Latest Patents:

Kasper Lamberth holds a total of 4 patents, with his latest inventions focusing on Factor VIII variants with decreased cellular uptake. These modified coagulation factors have the potential to revolutionize the treatment of certain medical conditions.

Career Highlights:

Throughout his career, Kasper Lamberth has worked with esteemed companies such as Novo Nordisk A/S and the Sanquin Blood Supply Foundation. His innovative spirit and dedication to excellence have been instrumental in driving forward advancements in the field.

Collaborations:

In his professional journey, Kasper Lamberth has collaborated with talented individuals like Henriet Meems and Alexander Benjamin Meijer. These partnerships have led to fruitful exchanges of ideas and the development of cutting-edge technologies.

Conclusion:

In conclusion, Kasper Lamberth's inventive prowess and commitment to innovation continue to inspire and shape the landscape of patents and inventions. His contributions have not only enriched the field but also have the potential to make a profound impact on society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…